Clinical Trial Update: A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

View source ↗

Summary

This clinical trial aims to generate real-world evidence on the effectiveness of guselkumab in treating inflammatory bowel disease, including ulcerative colitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen-Cilag G.m.b.H | Conditions: Inflammatory Bowel Disease, Colitis, Ulcerative | Status: RECRUITING